🇺🇸 FDA
Patent

US 11504427

Acoustic and ultrasound-based mechanogenetics and thermogenetics for immunotherapy

granted A61KA61K40/11A61K40/15

Quick answer

US patent 11504427 (Acoustic and ultrasound-based mechanogenetics and thermogenetics for immunotherapy) held by The Regents of the University of California expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61K, A61K40/11, A61K40/15, A61K40/17, A61K40/19